Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The primary objective of this study is to estimate the relative efficacy and assess the safety of CAIV-T compared to TIV.
Epistemonikos ID: bfc9d3c327d3368d18b830a3801ae87c48d12c42
First added on: May 04, 2024